| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/12/2001 | EP1161531A1 Tumor-associated antigen |
| 12/12/2001 | EP1161454A2 Peptides with anti-angiogenic activity |
| 12/12/2001 | EP1161448A1 49 human secreted proteins |
| 12/12/2001 | EP1161447A1 50 human secreted proteins |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161443A2 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof |
| 12/12/2001 | EP1161440A1 Method for refolding molecules of polypeptides containing ig domains |
| 12/12/2001 | EP1161439A1 Xylo-lna analogues |
| 12/12/2001 | EP1161436A1 Polyunsaturated fatty acid derivatives and their use |
| 12/12/2001 | EP1161433A1 Tyrosine kinase inhibitors |
| 12/12/2001 | EP1161432A1 Pharmaceutical composition based on polyaromatic compounds |
| 12/12/2001 | EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 12/12/2001 | EP1161430A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals |
| 12/12/2001 | EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors |
| 12/12/2001 | EP1161428A1 Pyrimidine compounds |
| 12/12/2001 | EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 12/12/2001 | EP1161417A1 Methods and compositions for treating leukemia |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161410A1 Retinoid antagonists and use thereof |
| 12/12/2001 | EP1161280A1 Use of an integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia |
| 12/12/2001 | EP1161266A1 Matriptase, a serine protease and its applications |
| 12/12/2001 | EP1161264A1 Polymer compositions for polynucleotide delivery |
| 12/12/2001 | EP1161262A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
| 12/12/2001 | EP1161258A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease |
| 12/12/2001 | EP1161257A2 Pharmaceutical compositions comprising tgf-beta |
| 12/12/2001 | EP1161250A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 12/12/2001 | EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/12/2001 | EP1161235A1 Combinations for the treatment of diseases involving angiogenesis |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/12/2001 | EP1161231A2 Method of inhibiting a chaperone protein |
| 12/12/2001 | EP1161147A1 Peptide mimics useful for treating disease |
| 12/12/2001 | EP1072272A4 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 12/12/2001 | EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/12/2001 | EP0934329B1 Glycoconjugates from modified camptothecin derivates (20-o-linkage) |
| 12/12/2001 | EP0836480B1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof |
| 12/12/2001 | EP0788356B1 Method and compositions for inhibiting protein kinases |
| 12/12/2001 | EP0782456B1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 12/12/2001 | EP0723540B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 12/12/2001 | EP0723539B1 Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 12/12/2001 | EP0723538B1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 12/12/2001 | EP0688213B1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 12/12/2001 | CN1326511A Systemic viral/ligand gene delivery system and gene therapy |
| 12/12/2001 | CN1326467A Expression and export of angiostation and endostatin as immunofusins |
| 12/12/2001 | CN1326466A Method of producing functional immunoglubulin superfaminly protein |
| 12/12/2001 | CN1326462A Betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 12/12/2001 | CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors |
| 12/12/2001 | CN1326455A Improved chemical process and pharmaceutical formulation |
| 12/12/2001 | CN1326449A Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2, 4-thiazolidinedione |
| 12/12/2001 | CN1326445A Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 12/12/2001 | CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells |
| 12/12/2001 | CN1326354A Immortalized human kerationocyte cell line |
| 12/12/2001 | CN1326353A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 12/12/2001 | CN1326345A Compounds for treatment of estrogen-dependent illnesses and methods for making and using same |
| 12/12/2001 | CN1325732A Nm-class magnetic material carrying radioisotope and its preparing process |
| 12/12/2001 | CN1325729A Application of R-phycoerythrin in preparing photosensitive medicine for phototherapy of tumor |
| 12/12/2001 | CN1325718A Freeze dried compound queen bee powder |
| 12/12/2001 | CN1325710A Tianjian capsule and its preparing process |
| 12/12/2001 | CN1325708A Multipurpose anticancer ointment |
| 12/12/2001 | CN1325707A Enterior-applied Chinese medicine for treating lung cancer |
| 12/12/2001 | CN1325695A Chinese-medicinal anticancer ointment |
| 12/12/2001 | CN1325690A Chinese medicine for treating cancers |
| 12/12/2001 | CN1075959C Radioactive particulate material, preparation and use thereof |
| 12/12/2001 | CN1075949C Auxiliary medicine for curing tumor and its preparation method |
| 12/11/2001 | US6329557 Dispersing saponified extract in water to form dispersion; mixing to form aqueous phase; separating from residue, contacting with nonpolar solvent to dissolve lipid-soluble compounds; separating precipitate; washing |
| 12/11/2001 | US6329503 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 12/11/2001 | US6329428 Therapy of disease of lower urinary tract system by using organic acid salt of (2-(4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)ethyl)-dimeth ylsulfonium |
| 12/11/2001 | US6329418 Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
| 12/11/2001 | US6329405 As ileal bile acid transporter inhibitor, for therapy of hyperlipemia |
| 12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 12/11/2001 | US6329397 Hydroxy pipecolate hydroxamic acid derivatives |
| 12/11/2001 | US6329388 Thienopyridine compounds, their production and use |
| 12/11/2001 | US6329373 Metalloproteinase inhibitors |
| 12/11/2001 | US6329365 Inhibitors of interleukin-1β converting enzyme |
| 12/11/2001 | US6329355 Method for inhibiting the growth of cancers |
| 12/11/2001 | US6329347 Anticarcinogenic agents using mycobacterium dna, delipidated, deproteinized cell walls |
| 12/11/2001 | US6329340 Human Defensin DEF-X |
| 12/11/2001 | US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues |
| 12/11/2001 | US6328978 Methods for the treatment of immunologically-mediated skin disorders |
| 12/11/2001 | US6328972 Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigens |
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | US6328967 Delivery system to modulate immune response |
| 12/11/2001 | US6328966 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | US6328956 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 12/11/2001 | US6328953 Polymeric derivatives of camptothecins |
| 12/11/2001 | US6328711 Chemo-thermo applicator for cancer treatment |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2213108C 2-aminobenzazapine derivatives |
| 12/11/2001 | CA2136094C Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
| 12/11/2001 | CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| 12/06/2001 | WO2001092892A2 Methods to identify compounds that modulate rage |
| 12/06/2001 | WO2001092876A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 12/06/2001 | WO2001092584A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092578A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 12/06/2001 | WO2001092565A2 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 12/06/2001 | WO2001092551A2 Duplexed parvovirus vectors |
| 12/06/2001 | WO2001092549A2 Method and composition for targeting an adenoviral vector |
| 12/06/2001 | WO2001092543A2 Improved methods of transfection |